· Regulation · Regulation Desk
Cathelicidin (LL-37), GHK-Cu, dihexa acetate, melanotan II, and PEG-MGF are queued for the next PCAC round before February 2027. Continued scheduling suggests the pathway is not stalling despite staff objections.
This brief is part of the Novusyn Research news desk. We track peptide clinical readouts, regulatory actions, and pharma developments in neutral, evidence-led language for scientifically literate readers.
For related context, see the full news desk, clinical trials tracker, regulation tracker, compound directory, and guides library.